SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-039795
Filing Date
2013-05-10
Accepted
2013-05-09 21:28:00
Documents
15
Period of Report
2013-05-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-11872_18k.htm 8-K 31067
2 EX-99.1 a13-11872_1ex99d1.htm EX-99.1 147429
3 EX-99.2 a13-11872_1ex99d2.htm EX-99.2 114320
4 EX-99.3 a13-11872_1ex99d3.htm EX-99.3 76126
5 GRAPHIC g118721mmi001.jpg GRAPHIC 18571
6 GRAPHIC g118721mmi002.jpg GRAPHIC 16745
7 GRAPHIC g118721mmi003.jpg GRAPHIC 16135
8 GRAPHIC g118721mqi001.jpg GRAPHIC 9006
9 GRAPHIC g118721mqi002.jpg GRAPHIC 17845
10 GRAPHIC g118721mqi003.jpg GRAPHIC 11966
11 GRAPHIC g118721mqi004.jpg GRAPHIC 13528
12 GRAPHIC g118721moi001.jpg GRAPHIC 18873
13 GRAPHIC g118721moi002.jpg GRAPHIC 18800
14 GRAPHIC g118721moi003.jpg GRAPHIC 18661
15 GRAPHIC g118721moi004.jpg GRAPHIC 18031
  Complete submission text file 0001104659-13-039795.txt   617229
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 13830860
SIC: 2834 Pharmaceutical Preparations